Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Juthamas Sukbuntherng
Ibrutinib Inhibits ERBB Receptor Tyrosine Kinases and HER2-Amplified Breast Cancer Cell Growth
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Tyrosine Kinase Signalling in Breast Cancer: ErbB Family Receptor Tyrosine Kinases
Breast Cancer Research
Cancer Research
Oncology
Drug-Induced Ubiquitylation and Degradation of ErbB Receptor Tyrosine Kinases: Implications for Cancer Therapy
EMBO Journal
Immunology
Molecular Biology
Biochemistry
Microbiology
Neuroscience
Medicine
Genetics
HER2-Targeted Hybrid Peptide That Blocks HER2 Tyrosine Kinase Disintegrates Cancer Cell Membrane and Inhibits Tumor Growth in Vivo
Molecular Cancer Therapeutics
Cancer Research
Oncology
ErbB2 Is Necessary for Induction of Carcinoma Cell Invasion by Erbb Family Receptor Tyrosine Kinases
Journal of Cell Biology
Medicine
Cell Biology
Receptor Tyrosine Kinases (RTKs) in Breast Cancer: Signaling, Therapeutic Implications and Challenges
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
ErbB Tyrosine Kinases and the Two Neuregulin Families Constitute a Ligand-Receptor Network
Molecular and Cellular Biology
Cell Biology
Molecular Biology
Receptor Tyrosine Kinases and Inhibitors in Lung Cancer
The Scientific World Journal
Biochemistry
Medicine
Genetics
Molecular Biology
Environmental Science
Dacomitinib (PF-00299804), an Irreversible Pan-Her Inhibitor, Inhibits Proliferation of HER2-Amplified Breast Cancer Cell Lines Resistant to Trastuzumab and Lapatinib
Molecular Cancer Therapeutics
Cancer Research
Oncology
Exploring Receptor Tyrosine Kinases-Inhibitors in Cancer Treatments
Egyptian Journal of Medical Human Genetics
Genetics
